321 related articles for article (PubMed ID: 16803684)
1. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype.
Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Moriyama I; Fukuhara H; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
Scand J Gastroenterol; 2006 Aug; 41(8):873-9. PubMed ID: 16803684
[TBL] [Abstract][Full Text] [Related]
2. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus: a discrepancy between macroscopic and histological diagnosis.
Endlicher E; Rümmele P; Beer S; Knüchel R; Rath H; Schlottmann K; Grossmann J; Woenckhaus U; Schölmerich J; Messmann H
Endoscopy; 2005 Nov; 37(11):1131-5. PubMed ID: 16281145
[TBL] [Abstract][Full Text] [Related]
4. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
[TBL] [Abstract][Full Text] [Related]
5. REG Ialpha protein expression in Barrett's esophagus.
Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
[TBL] [Abstract][Full Text] [Related]
6. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
[TBL] [Abstract][Full Text] [Related]
7. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions.
Yuki T; Amano Y; Kushiyama Y; Takahashi Y; Ose T; Moriyama I; Fukuhara H; Ishimura N; Koshino K; Furuta K; Ishihara S; Adachi K; Kinoshita Y
Dig Liver Dis; 2006 May; 38(5):296-300. PubMed ID: 16542886
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus: prevalence and size of hiatal hernia.
Cameron AJ
Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
[TBL] [Abstract][Full Text] [Related]
10. Expression of mucin-2 and correlation with PAS-alcian blue stain in Barrett's esophagus.
Lopes CV; Pereira-Lima J; Hartmann A
Hepatogastroenterology; 2006; 53(70):511-5. PubMed ID: 16995451
[TBL] [Abstract][Full Text] [Related]
11. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
12. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
14. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus.
Amano Y; Kushiyama Y; Ishihara S; Yuki T; Miyaoka Y; Yoshino N; Ishimura N; Fujishiro H; Adachi K; Maruyama R; Rumi MA; Kinoshita Y
Am J Gastroenterol; 2005 Jan; 100(1):21-6. PubMed ID: 15654776
[TBL] [Abstract][Full Text] [Related]
15. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
[TBL] [Abstract][Full Text] [Related]
17. Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia.
Benipal P; Garewal HS; Sampliner RE; Martinez P; Hayden CW; Fass R
Am J Gastroenterol; 2001 Nov; 96(11):3084-8. PubMed ID: 11721753
[TBL] [Abstract][Full Text] [Related]
18. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy.
Eloubeidi MA; Provenzale D
Am J Gastroenterol; 1999 Apr; 94(4):937-43. PubMed ID: 10201460
[TBL] [Abstract][Full Text] [Related]
19. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]